Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis/Experiment 1/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Peace Sandy on 2024-1-25
Curated date: 2022/10/09
Curator: Mary Bearkland
Revision editor(s): Mary Bearkland, Aiyshaaaa, Peace Sandy
Source: Supp table S3
Description: Linear discriminant analysis effect size (LDA) from phylum to species level shows differentially enriched taxa in NR and R groups. Related to Figure 4. R, response; NR, non-response.
Abundance in Group 1: increased abundance in Responders (Partial Response or Stable Disease)
| NCBI | Quality Control | Links |
|---|---|---|
| Dialister massiliensis | ||
| Selenomonadales | ||
| Veillonellales | ||
| Paraprevotella |
Revision editor(s): Mary Bearkland, Aiyshaaaa, Peace Sandy
